Skip to main content
. Author manuscript; available in PMC: 2024 Jul 23.
Published in final edited form as: FASEB J. 2023 Mar;37(3):e22825. doi: 10.1096/fj.202201972RR

TABLE 2.

Clinical characteristics of NAFLD and healthy subjects assessed for plasma biomarker measurements.

Characteristics NAFLD
(N = 67)
Healthy controls
(N = 78)
Sex (male, female) 22, 45 47, 32
Age (years), mean ± SD 64.7 ± 8.3 53.7 ± 16.8
African American (n, %) 1 (1.5%) 8 (10.3)
European American (n, %) 56 (82.1%) 45 (57.7)
Native American (n, %) 6 (8.9) 1 (1.2)
Ethnicity: Latino (n, %) 27 (41.8) 10 (12.8)
Type 2 diabetes (n, %) 35 (52.2) NA
Hypertension (n, %) 47 (70.1) NA
Dyslipidemia 27 (40.3) NA